logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
J

Janet B. McGill

Washington University in St. Louis

85H-index
400Paper Count
2.8WCitation Count
Published Papers 152
Publication Date
logo
Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Albuminuria Irrespective of Baseline HbA1c Levels: A Participant-Level Exploratory Analysis of the Randomised CONFIDENCE Trial
errDIABETES OBESITY & METABOLISM
IF5.7
err2026-08-05
err0
errOAAI
errJanet B. McGill; Jennifer B. Green; Hiddo J. L. Heerspink; Johannes F. E. Mann; Amy K. Mottl; Julio Rosenstock; Peter Rossing; Muthiah Vaduganathan; Masaomi Nangaku; Meike Brinker; Charlie Scott; Katja Rohwedder; Li Li; Na Li; Margarida Seco; Rajiv Agarwal
errShare
errSave
Early Hemodynamic Safety of Simultaneous Initiation of Finerenone and Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
errJACC
IF0
err2026-04-01
err0
errOAAI
errMuthiah Vaduganathan; Jennifer B. Green; Hiddo J.L. Heerspink; Johannes F.E. Mann; Janet B. McGill; Amy Mottl; Masaomi Nangaku; Julio Rosenstock; Peter Rossing; Na Li; Charlie Scott; Rajiv Agarwal
errShare
errSave
Sexual dimorphism and age effects in CKD and type 2 diabetes in the CONFIDENCE trial
errNephrology Dialysis Transplantation
IF5.6
err2026-04-01
err0
PREAI
errAgarwal, Rajiv; Green, Jennifer B.; Heerspink, Hiddo J. L.; Mann, Johannes F. E.; McGill, Janet B.; Mottl, Amy K.; Nangaku, Masaomi; Rosenstock, Julio; Vaduganathan, Muthiah; Scott, Charlie; Li, Li; Li, Na; Aldworth, Carolina; Brinker, Meike; Rossing, Peter
errShare
errSave
The Importance of Expanding Medicare Continuous Glucose Monitoring Coverage for High-Risk Hypoglycemia
errDiabetes Technology & Therapeutics
IF6.3
err2025-11-21
err0
errOAAI
errMary Elizabeth Patti; Grazia Aleppo; Davida Kruger; Carol J. Levy; Jesse Bushman; Guillermo Umpierrez; Rodolfo J. Galindo; Gregory P. Forlenza; Anders L. Carlson; Janet B. McGill
errShare
errSave
Risk of Hyperkalemia With Empagliflozin, Finerenone, or Both: Secondary Analysis of CONFIDENCE Randomized Trial
errJACC
IF0
err2025-11-07
err0
errOAAI
errRajiv Agarwal; Jennifer B. Green; Hiddo J.L. Heerspink; Janet B. McGill; Amy Mottl; Masaomi Nangaku; Julio Rosenstock; Peter Rossing; Muthiah Vaduganathan; Carolina Solis-Herrera; Charlie Scott; Li Li; Meike Brinke; Carolina Aldworth; Johannes F.E. Mann
errShare
errSave
Baseline Kidney Function, Albuminuria, and Urine Albumin-Creatinine Ratio Reduction with Finerenone, Empagliflozin, or Both Post Hoc Analyses of CONFIDENCE Trial
errJOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
IF9.4
err2025-11-01
err0
PREAI
errMottl, Amy; Scott, Charlie; Green, Jennifer B.; Heerspink, Hiddo J. L.; Mann, Johannes F. E.; Mcgill, Janet B.; Nangaku, Masaomi; Rosenstock, Julio; Rossing, Peter; Li, Li; Li, Na; Vaduganathan, Muthiah; Agarwal, Rajiv
errShare
errSave
Comparing CKD populations with T1D and T2D: a perspective based on the FINE-ONE and FIDELITY populations
errNephrology Dialysis Transplantation
IF5.6
err2025-10-01
err0
errOAAI
errHeerspink, Hiddo J. L.; Agarwal, Rajiv; Amor, Antonio J.; Bech, Jesper N.; Cherney, David Z., I; Fiorina, Paolo; Rossing, Peter; Schousboe, Karoline; Selby, Nicholas M.; Anker, Stefan D.; Filippatos, Gerasimos; Pitt, Bertram; Ruilope, Luis M.; Lawatscheck, Robert; Brinker, Meike; Russell, Julie; Schloemer, Patrick; Mcgill, Janet B.
errShare
errSave
Impact of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-Creatinine Ratio in Asia. Pre-Specified Analysis of CONFIDENCE
errCLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
IF7.1
err2025-09-01
err2
errOAAI
errAgarwal, Rajiv; Green, Jennifer B.; Heerspink, Hiddo J. L.; Mann, Johannes F. E.; Mcgill, Janet B.; Mottl, Amy; Osonoi, Takeshi; Pal, Atanu; Rossing, Peter; Rosenstock, Julio; Vaduganathan, Muthiah; Li, Li; Li, Na; Scott, Charlie; Manjrekar, Pravin; Yamashita, Satoshi; Nangaku, Masaomi
errShare
errSave
Simultaneous initiation of finerenone and empagliflozin across the spectrum of kidney risk in the CONFIDENCE trial
errNephrology Dialysis Transplantation
IF5.6
err2025-08-01
err0
errOAAI
errVaduganathan, Muthiah; Green, Jennifer B.; Heerspink, Hiddo J. L.; Kim, Sung Gyun; Mann, Johannes F. E.; McGill, Janet B.; Mottl, Amy; Nangaku, Masaomi; Rosenstock, Julio; Rossing, Peter; Li, Li; Li, Na; Rohwedder, Katja; Scott, Charlie; Agarwal, Rajiv
errShare
errSave
Breath Acetone Correlates With Capillary β-hydroxybutyrate in Type 1 Diabetes
errJOURNAL OF DIABETES SCIENCE AND TECHNOLOGY
IF3.7
err2025-04-22
err0
PREAI
errKai E. Jones; Max C. Petersen; Alexander M. Markov; Maamoun Salam; Petra Krutilova; Alexis M. McKee; Kathryn L. Bohnert; Samantha E. Adamson; Janet B. McGill
errShare
errSave
Addressing the Diabetes Tsunami Requires Expanded Access to Diabetes Technologies
errJOURNAL OF DIABETES SCIENCE AND TECHNOLOGY
IF3.7
err2025-04-10
err0
PREAI
errDavida F. Kruger; Christopher G. Parkin; Irl B. Hirsch; Grazia Aleppo; Janet B. McGill; Rodolfo J. Galindo; Carol J. Levy; Guillermo E. Umpierrez; George Grunberger; Richard M. Bergenstal
errShare
errSave
Effect of dapagliflozin on blood and breath ketones during supervised insulin withdrawal in adults with type 1 diabetes: A randomized crossover trial
errDIABETES OBESITY & METABOLISM
IF5.7
err2025-03-01
err0
PREAI
errPetersen, Max C.; Jones, Kai E.; Markov, Alexander M.; Salam, Maamoun; Krutilova, Petra; Mckee, Alexis M.; Bohnert, Kathryn L.; Adamson, Samantha E.; Mcgill, Janet B.
errShare
errSave
Beta-Hydroxybutyrate Levels and Risk of Diabetic Ketoacidosis in Adults with Type 1 Diabetes Treated with Sotagliflozin
errDIABETES TECHNOLOGY & THERAPEUTICS
IF6.3
err2024-09-01
err6
PREAI
errBoeder, Schafer; Davies, Michael J.; Mcgill, Janet B.; Pratley, Richard; Girard, Manon; Banks, Phillip; Pettus, Jeremy; Garg, Satish
errShare
errSave
Decreased sarcoplasmic reticulum phospholipids in human skeletal muscle are associated with metabolic syndrome
errJOURNAL OF LIPID RESEARCH
IF4.1
err2024-03-01
err0
errOAAI
errAdamson, Samantha E.; Adak, Sangeeta; Petersen, Max C.; Higgins, Dustin; Spears, Larry D.; Zhang, Rong Mei; Cedeno, Andrea; Mckee, Alexis; Kumar, Aswathi; Singh, Sudhir; Hsu, Fong-Fu; Mcgill, Janet B.; Semenkovich, Clay F.
errShare
errSave
Poor Glycemic Control Is Associated With More Rapid Kidney Function Decline After the Onset of Diabetic Kidney Disease
errJOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
IF5.1
err2024-01-23
err2
errOAAI
errShah, Hetal S.; Mcgill, Janet B.; Hirsch, Irl B.; Wu, Chunyi; Galecki, Andrzej; de Boer, Ian H.; Mauer, Michael; Doria, Alessandro
errShare
errSave
Longitudinal Effects of Glucose-Lowering Medications on β-Cell Responses and Insulin Sensitivity in Type 2 Diabetes: The GRADE Randomized Clinical Trial
errDIABETES CARE
IF16.6
err2024-01-11
err6
errOAAI
errRasouli, Neda; Younes, Naji; Ghosh, Alokananda; Albu, Jeanine; Cohen, Robert M.; DeFronzo, Ralph A.; Diaz, Elsa; Kassem, Laure Sayyed; Luchsinger, Jose A.; McGill, Janet B.; Sivitz, William I.; Tamborlane, William V.; Utzschneider, Kristina M.; Kahn, Steven E.
errShare
errSave
Coverage for Continuous Glucose Monitoring for Individuals with Type 2 Diabetes Treated with Nonintensive Therapies: An Evidence-Based Approach to Policymaking
errDIABETES TECHNOLOGY & THERAPEUTICS
IF6.3
err2023-10-01
err16
errOAAI
errAleppo, Grazia; Hirsch, Irl B.; Parkin, Christopher G.; McGill, Janet; Galindo, Rodolfo; Kruger, Davida F.; Levy, Carol J.; Forlenza, Gregory P.; Umpierrez, Guillermo E.; Grunberger, George; Bergenstal, Richard M.
errShare
errSave
Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: The FINE-ONE trial
errDIABETES RESEARCH AND CLINICAL PRACTICE
IF7.4
err2023-10-01
err12
errOAAI
errHeerspink, Hiddo J. L.; Birkenfeld, Andreas L.; Cherney, David Z. I.; Colhoun, Helen M.; Ji, Linong; Mathieu, Chantal; Groop, Per-Henrik; Pratley, Richard E.; Rosas, Sylvia E.; Rossing, Peter; Skyler, Jay S.; Tuttle, Katherine R.; Lawatscheck, Robert; Scott, Charlie; Edfors, Robert; Scheerer, Markus F.; Kolkhof, Peter; McGill, Janet B.
errShare
errSave
Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of major adverse cardiovascular events: emulation of a randomised target trial using electronic health records
errLANCET DIABETES & ENDOCRINOLOGY
IF41.8
err2023-09-01
err26
PREAI
errXie, Yan; Bowe, Benjamin; Xian, Hong; Loux, Travis; McGill, Janet B.; Al-Aly, Ziyad
errShare
errSave
Management of the 'wicked' combination of heart failure and chronic kidney disease in the patient with diabetes
errDIABETES OBESITY & METABOLISM
IF5.7
err2023-07-06
err6
errOAAI
errBell, David S. H.; McGill, Janet B. B.; Jerkins, Terri
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
J
John J.V. McMurray
H-index: 231 · Papers: 2.6K
G
Giuseppe Remuzzi
H-index: 201 · Papers: 2.1K
S
Scott D. Solomon
H-index: 188 · Papers: 2.0K
S
Stefan D. Anker
H-index: 162 · Papers: 1.2K
A
Andrew S. Levey
H-index: 162 · Papers: 1.0K
View more